J Korean Diabetes.  2019 Dec;20(4):210-214. 10.4093/jkd.2019.20.4.210.

Gastrointestinal Symptoms in Patients with Diabetes

• Kim MK

• KMID: 2468007
• DOI: http://doi.org/10.4093/jkd.2019.20.4.210

Abstract

Gastrointestinal symptoms are more common in people with diabetes than in the general population. Patients with diabetes, especially of long duration, have various symptoms such as postprandial fullness, nausea, vomiting, bloating, early satiety, and abdominal pain. These symptoms are related with autonomic abnormalities in gastrointestinal system and leads to reduction of quality of life. In addition, some medications are associated with gastrointestinal symptoms. In this article, I reviewed assessment and management of the gastrointestinal symptoms in diabetes.

Keyword

Diabetes mellitus; Gastrointestinal diseases

MeSH Terms

Abdominal Pain
Diabetes Mellitus
Gastrointestinal Diseases
Humans
Nausea
Quality of Life
Vomiting

Reference

1. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes Care. 2018; 41:627–637.

2. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001; 161:1989–1996.

3. Meldgaard T, Keller J, Olesen AE, Olesen SS, Krogh K, Borre M, Farmer A, Brock B, Brock C, Drewes AM. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol. 2019; 12:1756284819852047.

4. Florez H, Luo J, Castillo-Florez S, Mitsi G, Hanna J, Tamariz L, Palacio A, Nagendran S, Hagan M. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med. 2010; 122:112–120.

5. Kumar A, Attaluri A, Hashmi S, Schulze KS, Rao SS. Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis. Neurogastroenterol Motil. 2008; 20:635–642.

6. Brock C, Søfteland E, Gunterberg V, Frøkjær JB, Lelic D, Brock B, Dimcevski G, Gregersen H, Simrén M, Drewes AM. Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. Diabetes Care. 2013; 36:3698–3705.

7. Rayner CK, Verhagen MA, Hebbard GS, DiMatteo AC, Doran SM, Horowitz M. Proximal gastric compliance and perception of distension in type 1 diabetes mellitus: effects of hyperglycemia. Am J Gastroenterol. 2000; 95:1175–1183.

8. Bharucha AE, Kudva YC, Prichard DO. Diabetic gastroparesis. Endocr Rev. 2019; 40:1318–1352.

9. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F. National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011; 9:1056–1064. quiz e133–4.

10. Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2010; 55:359–370.

11. Parkman HP, Hasler WL, Fisher RS;. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004; 127:1592–1622.

12. Urbain JL, Vantrappen G, Janssens J, Van Cutsem E, Peeters T, De Roo M. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med. 1990; 31:1490–1493.